Cancer patients get treatment at home in new trial
NCT ID NCT05511428
Summary
This study tested whether giving a standard multiple myeloma drug at home is a practical option for patients. Twenty adults already receiving the drug Darzalex Faspro received some of their injections at home instead of at the cancer center. The main goal was to see if home treatment reduced the burden of care and improved patient satisfaction, quality of life, and financial costs.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PLASMA CELL MYELOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Sidney Kimmel Cancer Center at Thomas Jefferson University
Philadelphia, Pennsylvania, 19107, United States
Conditions
Explore the condition pages connected to this study.